Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction‐Associated Steatohepatitis
Transitioning from simple steatosis to MASH is associated with distinct alterations in liver metabolites and systemic metabolic traits, highlighting disease progression-associated pathways.
Authors
- Bart Staels (ORCID: https://orcid.org/0000-0002-3784-1503)
- J Haas
- Emily Flam (ORCID: https://orcid.org/0000-0001-6262-1126)
- Delphine Eberlé (ORCID: https://orcid.org/0000-0003-2211-6146)
- Kirsi A. Virtanen (ORCID: https://orcid.org/0000-0001-6183-4525)
- Saana Palomurto (ORCID: https://orcid.org/0000-0001-6373-8932)
- Violeta Raverdy
- Päivi Pajukanta
- Dorota Kaminska
- Pirjo Käkelä
- François Pattou
- Ville Männistö
- Vesa Kärjä
- Robert Caiazzo
Institutions
- Inserm (FR)
- University of Turku (FI)
- University of California, Los Angeles (US)
- University of Eastern Finland (FI)
- UCLA Health (US)
- Institut Pasteur de Lille (FR)
- Turku University Hospital (FI)
- Centre Hospitalier Universitaire de Lille (FR)
- Kuopio University Hospital (FI)
- Turku PET Centre (FI)
Publication Details
- Journal
- Liver International
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1111/liv.70552
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Itä-Suomen Yliopisto
- Suomen Lääketieteen Säätiö
- Mary och Georg C. Ehrnrooths Stiftelse
- European Genomic Institute for Diabetes
- Agence Nationale de la Recherche
- Suomen Kulttuurirahasto
- Kuopion Yliopistollinen Sairaala
- Sigrid Juséliuksen Säätiö
- Diabetestutkimussäätiö